CA Patent

CA2588566A1 — Estrogenic extracts of morus alba and uses thereof

Assigned to Bionovo Inc · Expires 2006-06-22 · 20y expired

What this patent protects

Extracts of various species of the Moraceae family have estrogenic properties. For example, aqueous and ethanolic extracts of Morus alba L. species possess estrogenic properties in both ER.alpha.+ and ER.beta.+ cells. These estrogenic effect include estrogen response ele…

USPTO Abstract

Extracts of various species of the Moraceae family have estrogenic properties. For example, aqueous and ethanolic extracts of Morus alba L. species possess estrogenic properties in both ER.alpha.+ and ER.beta.+ cells. These estrogenic effect include estrogen response element (ERE) stimulation as well as tumor necrosis factor (TNF) repression. Methods are provided for treating climacteric symptoms, breast and/or uterine cancer, and osteoporosis.

Drugs covered by this patent

Patent Metadata

Patent number
CA2588566A1
Jurisdiction
CA
Classification
—
Expires
2006-06-22
Drug substance claim
No
Drug product claim
No
Assignee
Bionovo Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.